Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:25 AM
Ignite Modification Date:
2025-12-25 @ 2:25 AM
NCT ID:
NCT00720434
Eligibility Criteria:
Inclusion Criteria:
* Treatment naive (no prior treatment with IFN-a +/- RBV regimens.
* Subjects who have discontinued IFN-a containing regimens after \<2 weeks of therapy due to tolerability issues are considered treatment naive.
* HCV RNA \> 100,000 IU/mL at screening.
* Genotype 1.
* A diagnosis of chronic HCV infection for at least 6 months.
Exclusion Criteria:
* Evidence of acute or chronic infection with HIV or HBV.
* Exposure within the previous three months to an investigational anti-HCV agent.
* Evidence of severe or decompensated liver disease.
* Subjects with liver disease unrelated to HCV infection.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT00720434
Study Brief:
Protocol Section:
NCT00720434